Cargando…

Folate Intake and Methylenetetrahydrofolate Reductase Gene Polymorphisms as Predictive and Prognostic Biomarkers for Ovarian Cancer Risk

Folic acid and methylenetetrahydrofolate reductase (MTHFR) may affect the development of human cancer. However, few studies have evaluated folate intake and MTHFR in susceptibility to and prognosis of patients with ovarian cancer. We conducted a prospective case-control study in 215 ovarian cancer p...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Li, Liu, Wenxin, Hao, Quan, Bao, Lewen, Wang, Ke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Molecular Diversity Preservation International (MDPI) 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3344198/
https://www.ncbi.nlm.nih.gov/pubmed/22605962
http://dx.doi.org/10.3390/ijms13044009
_version_ 1782231937800208384
author Zhang, Li
Liu, Wenxin
Hao, Quan
Bao, Lewen
Wang, Ke
author_facet Zhang, Li
Liu, Wenxin
Hao, Quan
Bao, Lewen
Wang, Ke
author_sort Zhang, Li
collection PubMed
description Folic acid and methylenetetrahydrofolate reductase (MTHFR) may affect the development of human cancer. However, few studies have evaluated folate intake and MTHFR in susceptibility to and prognosis of patients with ovarian cancer. We conducted a prospective case-control study in 215 ovarian cancer patients and 218 controls (all Chinese) between Jan. 2004 and Jan. 2007. MTHFR C677T genotyping was done by PCR-RFLP. All patients were followed up until Dec. 2010. We found a 2.43-fold increased risk of ovarian cancer among MTHFR 677TT carriers, and a decreased risk of ovarian cancer in individuals with high folate intake (OR = 0.54, 95% CI = 0.32–0.94). Cox regression survival analysis showed that among the ovarian cancer patients, those carrying the 677TT genotype had a higher risk of death (HR = 2.17, 95% CI = 1.20–4.79), while high folate intake was associated with a lower risk of death (HR = 0.43, 95% CI = 0.33–0.88). Moreover, MTHFR 677CC carriers with higher folate intake showed a lower risk of death from ovarian cancer (HR = 0.32, 95% CI = 0.27–0.82). In summary, high folate intake may lessen susceptibility and improve the prognosis of ovarian cancer patients, while the MTHFR 677TT genotype appears to increase ovarian cancer risk and worsen its prognosis in a Chinese population.
format Online
Article
Text
id pubmed-3344198
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Molecular Diversity Preservation International (MDPI)
record_format MEDLINE/PubMed
spelling pubmed-33441982012-05-17 Folate Intake and Methylenetetrahydrofolate Reductase Gene Polymorphisms as Predictive and Prognostic Biomarkers for Ovarian Cancer Risk Zhang, Li Liu, Wenxin Hao, Quan Bao, Lewen Wang, Ke Int J Mol Sci Article Folic acid and methylenetetrahydrofolate reductase (MTHFR) may affect the development of human cancer. However, few studies have evaluated folate intake and MTHFR in susceptibility to and prognosis of patients with ovarian cancer. We conducted a prospective case-control study in 215 ovarian cancer patients and 218 controls (all Chinese) between Jan. 2004 and Jan. 2007. MTHFR C677T genotyping was done by PCR-RFLP. All patients were followed up until Dec. 2010. We found a 2.43-fold increased risk of ovarian cancer among MTHFR 677TT carriers, and a decreased risk of ovarian cancer in individuals with high folate intake (OR = 0.54, 95% CI = 0.32–0.94). Cox regression survival analysis showed that among the ovarian cancer patients, those carrying the 677TT genotype had a higher risk of death (HR = 2.17, 95% CI = 1.20–4.79), while high folate intake was associated with a lower risk of death (HR = 0.43, 95% CI = 0.33–0.88). Moreover, MTHFR 677CC carriers with higher folate intake showed a lower risk of death from ovarian cancer (HR = 0.32, 95% CI = 0.27–0.82). In summary, high folate intake may lessen susceptibility and improve the prognosis of ovarian cancer patients, while the MTHFR 677TT genotype appears to increase ovarian cancer risk and worsen its prognosis in a Chinese population. Molecular Diversity Preservation International (MDPI) 2012-03-23 /pmc/articles/PMC3344198/ /pubmed/22605962 http://dx.doi.org/10.3390/ijms13044009 Text en © 2012 by the authors; licensee Molecular Diversity Preservation International, Basel, Switzerland. http://creativecommons.org/licenses/by/3.0 This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).
spellingShingle Article
Zhang, Li
Liu, Wenxin
Hao, Quan
Bao, Lewen
Wang, Ke
Folate Intake and Methylenetetrahydrofolate Reductase Gene Polymorphisms as Predictive and Prognostic Biomarkers for Ovarian Cancer Risk
title Folate Intake and Methylenetetrahydrofolate Reductase Gene Polymorphisms as Predictive and Prognostic Biomarkers for Ovarian Cancer Risk
title_full Folate Intake and Methylenetetrahydrofolate Reductase Gene Polymorphisms as Predictive and Prognostic Biomarkers for Ovarian Cancer Risk
title_fullStr Folate Intake and Methylenetetrahydrofolate Reductase Gene Polymorphisms as Predictive and Prognostic Biomarkers for Ovarian Cancer Risk
title_full_unstemmed Folate Intake and Methylenetetrahydrofolate Reductase Gene Polymorphisms as Predictive and Prognostic Biomarkers for Ovarian Cancer Risk
title_short Folate Intake and Methylenetetrahydrofolate Reductase Gene Polymorphisms as Predictive and Prognostic Biomarkers for Ovarian Cancer Risk
title_sort folate intake and methylenetetrahydrofolate reductase gene polymorphisms as predictive and prognostic biomarkers for ovarian cancer risk
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3344198/
https://www.ncbi.nlm.nih.gov/pubmed/22605962
http://dx.doi.org/10.3390/ijms13044009
work_keys_str_mv AT zhangli folateintakeandmethylenetetrahydrofolatereductasegenepolymorphismsaspredictiveandprognosticbiomarkersforovariancancerrisk
AT liuwenxin folateintakeandmethylenetetrahydrofolatereductasegenepolymorphismsaspredictiveandprognosticbiomarkersforovariancancerrisk
AT haoquan folateintakeandmethylenetetrahydrofolatereductasegenepolymorphismsaspredictiveandprognosticbiomarkersforovariancancerrisk
AT baolewen folateintakeandmethylenetetrahydrofolatereductasegenepolymorphismsaspredictiveandprognosticbiomarkersforovariancancerrisk
AT wangke folateintakeandmethylenetetrahydrofolatereductasegenepolymorphismsaspredictiveandprognosticbiomarkersforovariancancerrisk